For media outside of the US, the UK & Canada only
Boehringer Ingelheim today announces the upcoming presentation of the latest efficacy and safety data for the novel oral anticoagulant Pradaxa® (dabigatran etexilate) at the 2013 American Heart Association’s (AHA) Scientific Sessions, 16-20 November 2013 in Dallas, USA. Data from eight presentations sponsored by Boehringer Ingelheim are included in the Scientific Programme, adding to the growing body of evidence
Help employers find you! Check out all the jobs and post your resume.
